TG Therapeutics
TGTX
TGTX
51 hedge funds and large institutions have $80.2M invested in TG Therapeutics in 2014 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 4 closing their positions.
Holders
51
Holders Change
+6
Holders Change %
+13.33%
% of All Funds
1.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
23
Reduced
10
Closed
4
Calls
$1.74M
Puts
$219K
Net Calls
+$1.52M
Net Calls Change
+$1.55M
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$19.5M |
| 2 |
BM
2
Bridger Management
New York
|
$17.6M |
| 3 |
SFM
3
Sphera Funds Management
Tel Aviv,
Israel
|
$1.38M |
| 4 |
TC
4
TFS Capital
West Chester,
Pennsylvania
|
$1.24M |
| 5 |
5
Morgan Stanley
New York
|
$769K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SM
51
Sabby Management
Miami Beach,
Florida
| – | – | -66,000 | Closed |
|
52
Two Sigma Investments
New York
| – | – | -11,765 | Closed |
|
|
CS
53
Credit Suisse
Zurich,
Switzerland
| – | – | -11,014 | Closed |
|
54
Bank of America
Charlotte,
North Carolina
| $0 | 27 | -506 | -95% |
|
55
Bessemer Group
Woodbridge,
New Jersey
| $0 | 2 | – | – |
|
|
PAAMCP
56
Pacific Alternative Asset Management Company (PAAMCO)
Irvine,
California
| – | – | – | – |
|
57
Wells Fargo
San Francisco,
California
| $0 | 4 | – | – |
|